Caution in the interpretation of safety and efficacy differences in clinical trials comparing aminosalicylates for ulcerative colitis [3]

Stephen B. Hanauer*

*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Caution in the interpretation of safety and efficacy differences in clinical trials comparing aminosalicylates for ulcerative colitis [3]'. Together they form a unique fingerprint.